Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SAB Biotherapeutics (SABS) Shares Outstanding: 2020-2024

Historic Shares Outstanding for SAB Biotherapeutics (SABS) over the last 5 years, with Dec 2024 value amounting to $9.3 million.

  • SAB Biotherapeutics' Shares Outstanding rose 412.16% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.5 million, marking a year-over-year increase of 412.16%. This contributed to the annual value of $9.3 million for FY2024, which is 0.68% up from last year.
  • As of FY2024, SAB Biotherapeutics' Shares Outstanding stood at $9.3 million, which was up 0.68% from $9.3 million recorded in FY2023.
  • Over the past 5 years, SAB Biotherapeutics' Shares Outstanding peaked at $26.0 million during FY2020, and registered a low of $4.3 million during FY2021.
  • In the last 3 years, SAB Biotherapeutics' Shares Outstanding had a median value of $9.3 million in 2023 and averaged $7.9 million.
  • In the last 5 years, SAB Biotherapeutics' Shares Outstanding crashed by 83.26% in 2021 and then skyrocketed by 82.18% in 2023.
  • SAB Biotherapeutics' Shares Outstanding (Yearly) stood at $26.0 million in 2020, then plummeted by 83.26% to $4.3 million in 2021, then climbed by 17.14% to $5.1 million in 2022, then surged by 82.18% to $9.3 million in 2023, then increased by 0.68% to $9.3 million in 2024.